A Comparative Study of Bioavailability of 3 New Abiraterone Acetate Tablets With Current Commercial Tablet
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (what the body does to the
medication) and relative bioavailability of 3 newly developed abiraterone acetate tablet
formulations compared with the current commercial abiraterone acetate tablet formulation in
healthy male participants, under fasted conditions, at a single dose of 1000 mg.